Recapitulating intracavitary brachytherapy in cervical cancer patients during the COVID-19 pandemic: a viewpoint-Reference-Cited by-同舟云学术

Recapitulating intracavitary brachytherapy in cervical cancer patients during the COVID-19 pandemic: a viewpoint

Published:2020-10 Issue:28 Volume:16 Page:2143-2146
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Kumar Divyesh¹^ORCID,Dey Treshita¹^ORCID

Affiliation:

1. Department of Radiotherapy & Oncology, PGIMER, Chandigarh 160012, India

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2020-0588

Reference14 articles.

1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

2. Risk of COVID-19 for patients with cancer

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. NHS England. Clinical guide for the management of noncoronavirus patients requiring acute treatment: cancer (2020). www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-acute-treatment-cancer-23-march-2020.pdf

5. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo–radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic;Radiation Oncology;2023-03-20

2. Radiotherapy Management of Locally Advanced Cervical Cancer during the COVID-19 Era: A Single Centre Report on Treatment Approach, Brachytherapy Fractionation and Timing;Clinical and Experimental Obstetrics & Gynecology;2022-10-28

3. Covid-19 and radiotherapy: a systematic review after 2 years of pandemic;Clinical and Translational Imaging;2022-07-23

4. Radiotherapy based management during Covid-19 pandemic – A systematic review of presented consensus and guidelines;Critical Reviews in Oncology/Hematology;2021-08